Skip to main content

Advertisement

Log in

Geraniol modulates cell proliferation, apoptosis, inflammation, and angiogenesis during 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Oral carcinogenesis, a multistep process with multifaceted etiology, arises due to accumulation of heterogeneous genetic changes in the genes involved in the basic cellular functions including cell division, differentiation, and cell death. These genetic changes in the affected cell progressively increase the cell proliferation, angiogenesis, and inhibition of apoptosis. The present study investigated the modulating effect of geraniol on the expression pattern of cell proliferative (PCNA, cyclin D1, c-fos), inflammatory (NF-κB, COX-2), apoptotic (p53, Bax, Bcl-2, caspase-3 and -9), and angiogenic (VEGF) markers in 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch carcinogenesis. Topical application of 0.5 % DMBA in liquid paraffin, three times a week, for 14 weeks, developed well-differentiated squamous cell carcinoma (SCC) in the buccal pouch of golden Syrian hamsters. All the hamsters treated with DMBA alone (100 %) developed oral tumors in the buccal pouch after 14 weeks. Over-expression of mutant p53, PCNA, Bcl-2, and VEGF accompanied by decreased expression of Bax were noticed in hamsters treated with DMBA alone. Increased expression of c-fos, COX-2, NF-κB, and cyclin D1 and decreased activities of caspase-3 and -9 were also noticed in hamsters treated with DMBA alone. Oral administration of geraniol at a dose of 250 mg/kg bw (body weight) not only completely prevented the formation of oral tumors but also prevented the deregulation in the expression of above mentioned molecular markers in hamsters treated with DMBA. The present results thus suggest that geraniol has potent anti-inflammatory, anti-angiogenic, anti-cell proliferative, and apoptosis-inducing properties in DMBA-induced hamster buccal pouch carcinogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Scully C, Bagan J (2009) Oral squamous cell carcinoma overview. Oral Oncol 45:301–308

    Article  PubMed  CAS  Google Scholar 

  2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71–96

    Article  PubMed  Google Scholar 

  3. Shimada T (2006) Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet 2:257–276

    Article  Google Scholar 

  4. Manoharan S, Vasanthaselvan M, Silvan S, Baskaran N, Kumar Singh A, Vinothkumar V (2010) Carnosic acid: a potent chemopreventive agent against oral carcinogenesis. Chem Biol Interact 188:616–622

    Article  PubMed  CAS  Google Scholar 

  5. Oren M (2003) Decision making by p53: life, death and cancer. Cell Death Differ 10:431–442

    Article  PubMed  CAS  Google Scholar 

  6. Goulart Filho JA, Nonaka CF, da Costa Miguel MC, de Almeida FreitasR, Galvao HC (2009) Immunoexpression of cyclooxygenase-2 and p53 in oral squamous cell carcinoma. Am J Otolaryngol 30:89–94

    Article  PubMed  Google Scholar 

  7. Chin D, Boyle GM, Theile DR, Parsons PG, Coman WB (2004) Molecular introduction to head and neck cancer (HNSCC) carcinogenesis. Br J Plast Surg 57:595–602

    Article  PubMed  Google Scholar 

  8. Tsujimoto Y (2003) Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol 195:158–167

    Article  PubMed  CAS  Google Scholar 

  9. Zhang M, Zhang P, Zhang C, Sun J, Wang L, Li J, Tian Z, Chen W (2009) Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma. J Oral Pathol Med 38:307–313

    Article  PubMed  CAS  Google Scholar 

  10. Saitoh M, Nagai K, Nakagawa K, Yamamura T, Yamamoto S, Nishizaki T (2004) Adenosine induces apoptosis in the human gastric cancer cells via an intrinsic pathway relevant to activation of AMP-activated protein kinase. Biochem Pharmacol 67:2005–2011

    Article  PubMed  CAS  Google Scholar 

  11. Lawall MA, Crivelini MM (2006) PCNA and p53 expression in oral leukoplakia with different degrees of keratinization. J Appl Oral Sci 14:276–280

    Article  Google Scholar 

  12. Cheng HC, Chien H, Liao CH, Yang YY, Huang SY (2007) Carotenoids suppress proliferating cell nuclear antigen and cyclin D1 expression in oral carcinogenic models. J Nutr Biochem 18:667–675

    Article  PubMed  CAS  Google Scholar 

  13. Zhou P, Jiang W, Weghorst CM, Weinstein IB (1996) Overexpression of cyclin D1 enhances gene amplification. Cancer Res 56:36–39

    PubMed  CAS  Google Scholar 

  14. Lim YC, Lee SH, Song MH, Yamaguchi K, Yoon JH, Choi EC, Baek SJ (2006) Growth inhibition and apoptosis by (−)-epicatechin gallate are mediated by cyclin D1 suppression in head and neck squamous carcinoma cells. Eur J Cancer 42:3260–3266

    Article  PubMed  CAS  Google Scholar 

  15. Lu C, Shen Q, DuPre E, Kim H, Hilsenbeck S, Brown PH (2005) cFos is critical for MCF-7 breast cancer cell growth. Oncogene 24:6516–6524

    Article  PubMed  CAS  Google Scholar 

  16. Sethi G, Tergaonkar V (2009) Potential pharmacological control of the NF-κB pathway. Trends Pharmacol Sci 30:313–321

    Article  PubMed  CAS  Google Scholar 

  17. Smith WL, Garavito RM, DeWitt DL (1996) Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271:33157–33160

    Article  PubMed  CAS  Google Scholar 

  18. Urade Masahiro (2008) Cyclooxygenase (COX)-2 as a potent molecular target for prevention and therapy of oral cancer. Jpn Dent Sci Rev 44:57–65

    Article  Google Scholar 

  19. Lyons JM 3rd, Schwimer JE, Anthony CT, Thomson JL, Cundiff JD, Casey DT, Maccini C, Kucera P, Wang YZ, Boudreaux JP, Woltering EA (2010) The Role of VEGF Pathways in human physiologic and pathologic angiogenesis. J Surg Res 159:517–527

    Article  PubMed  CAS  Google Scholar 

  20. Tiwari M, Kakkar P (2009) Plant derived antioxidants-Geraniol and camphene protects rat alveolar macrophages against t-BHP induced oxidative stress. Toxicol in Vitro 23:295–301

    Article  PubMed  CAS  Google Scholar 

  21. Chen W, Viljoen AM (2010) Geraniol—A review of a commercially important fragrance material. S Afr J Bot 76:643–651

    Article  CAS  Google Scholar 

  22. Carnesecchi S, Bras-Goncalves R, Bradaia A, Zeisel M, Gosse F, Poupon MF, Raul F (2004) Geraniol, a component of plant essential oils, modulates DNA synthesis and potentiates 5-fluorouracil efficacy on human colon tumor xenografts. Cancer Lett 215:53–59

    Article  PubMed  CAS  Google Scholar 

  23. Cardozo MT, de Conti A, Ong TP, Scolastici C, Purgatto E, Horst MA, Bassoli BK, Moreno FS (2011) Chemopreventive effects of β-ionone and geraniol during rat hepatocarcinogenesis promotion: distinct actions on cell proliferation, apoptosis, HMGCoA reductase, and RhoA. J Nutr Biochem 22:130–135

    Article  PubMed  CAS  Google Scholar 

  24. Vinothkumar V, Manoharan S (2011) Chemopreventive efficacy of geraniol against 7,12-dimethylben[a] anthracene -induced hamster buccal pouch carcinogenesis. Redox Rep 16:91–100

    Article  PubMed  CAS  Google Scholar 

  25. Vinothkumar V, Manoharan S, Palanimuthu D, Rajasekaran D, Srinivasan R, Afaqwani S (2011) Geraniol protects cell surface glycoconjugates abnormalities during 7,12-dimethylbenz(a)anthracene-induced oral carcinogenesis. J Cell Tissue Res 11:2759–2764

    CAS  Google Scholar 

  26. Lyzogubov V, Khozhaenko Y, Usenko V, Antonjuk S, Ovcharenko G, Tikhonkova I, Fillonenko V (2008) Immunohistochemical analysis of Ki-67, PCNA and S6K1/2 expression in human breast cancer. Exp Oncol 27:141–144

    Google Scholar 

  27. Kim SH, Park EJ, Lee CR, Chun JN, Cho NH, Kim IG, Lee S, Kim TW, Park HH, So I, Jeon JH (2012) Geraniol induces cooperative interaction of apoptosis and autophagy to elicit cell death in PC-3 prostate cancer cells. Int J Oncol 40:1683–1690

    PubMed  CAS  Google Scholar 

  28. Polo MP, Crespo R, de Bravo MG (2011) Geraniol and simvastatin show a synergistic effect on a human hepatocarcinoma cell line. Cell Biochem Funct 29:452–458

    Article  PubMed  CAS  Google Scholar 

  29. Acha-Sagredo A, Ruesga MT, Rodriguez C, Aguirregaviria JI, de Pancorbo MM, Califano JA, Aguirre JM (2009) p53 mutation is rare in oral mucosa brushings from patients previously treated for a head and neck squamous cell carcinoma. Oral Oncol 45:661–664

    Article  PubMed  CAS  Google Scholar 

  30. Panjamurthy K, Manoharan S, Nirmal MR, Vellaichamy L (2009) Protective role of Withaferin-A on immunoexpression of p53 and bcl-2 in 7,12-dimethylbenz(a)anthracene-induced experimental oral carcinogenesis. Invest New Drugs 27:447–452

    Article  PubMed  CAS  Google Scholar 

  31. Marzo I, Naval J (2008) Bcl-2 family members as molecular targets in cancer therapy. Biochem Pharmacol 76:939–946

    Article  PubMed  CAS  Google Scholar 

  32. Krajewski S, Blomqvist C, Franssila K, Krajewska M, Wasenius VM, Niskanen E, Nordling S, Reed JC (1995) Reduced expression of proapoptotic gene Bax is associated with poor response rate to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res 55:4471–4478

    PubMed  CAS  Google Scholar 

  33. Balakrishnan S, Manoharan S, Alias LM, Nirmal MR (2010) Effect of curcumin and ferulic acid on modulation of expression pattern of p53 and bcl-2 proteins in 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis. Indian J Biochem Biophys 47:7–12

    PubMed  CAS  Google Scholar 

  34. Okada H, Mak TW (2004) Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer 4:592–603

    Article  PubMed  CAS  Google Scholar 

  35. Hsu WH, Lee BH, Pan TM (2011) Effects of red mold dioscorea on oral carcinogenesis in DMBA-induced hamster animal model. Food Chem Toxicol 49:1292–1297

    Article  PubMed  CAS  Google Scholar 

  36. Bishayee A, Dhir N (2009) Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepato carcinogenesis: inhibition of cell proliferation and induction of apoptosis. Chem Biol Interact 179:131–144

    Article  PubMed  CAS  Google Scholar 

  37. Barnes DM, Gillett CE (1998) Cyclin D1 in breast cancer. Breast Cancer Res Treat 52:1–15

    Article  PubMed  CAS  Google Scholar 

  38. Bova RJ, Quinn DI, Nankervis JS, Cole IE, Sheridan RL, Jensen MJ, Morgan GJ, Hughes CJ, Sutherland RL (1999) Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. Clin Cancer Res 5:2810–2889

    PubMed  CAS  Google Scholar 

  39. Wu MY, Zhuang CX, Yang HX, Liang YR (2004) Expression of Egr-1, c-fos and cyclin D1 in esophageal cancer and its precursors: an immunohistochemical and in situ hybridization study. World J Gastroenterol 10:476–480

    PubMed  CAS  Google Scholar 

  40. Huang MT, Newmark HL, Frenkel K (1997) Inhibitory effects of curcumin on tumorigenesis in mice. J Cell Biochem Suppl 27:26–34

    Article  PubMed  CAS  Google Scholar 

  41. Chen F, Castranova V, Shi X (2001) New insights into the role of nuclear factor-kappaB in cell growth regulation. Am J Pathol 159:387–397

    Article  PubMed  CAS  Google Scholar 

  42. Huang S, Pettaway CA, Uehara H, Bucana CD, Fidler IJ (2001) Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene 20:4188–4197

    Article  PubMed  CAS  Google Scholar 

  43. Kundu JK, Surh YJ (2004) Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets. Mutat Res 555:65–80

    Article  PubMed  CAS  Google Scholar 

  44. Lee DW, Sung MW, Park SW, Seong WJ, Roh JL, Park B, Heo DS, Kim KH (2002) Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs. Anticancer Res 22:2089–2096

    PubMed  CAS  Google Scholar 

  45. Cho NP, Han HS, Leem DH, Choi IS, Jung JY, Kim HJ, Moon KS, Choi KH, Soh Y, Kong G, Cho SD, Choi SH (2009) Sulforaphane enhances caspase-dependent apoptosis through inhibition of cyclooxygenase-2 expression in human oral squamous carcinoma cells and nude mouse xenograft model. Oral Oncol 45:654–660

    Article  PubMed  CAS  Google Scholar 

  46. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN (1994) Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183–1188

    PubMed  CAS  Google Scholar 

  47. Rykala J, Przybylowska K, Majsterek I, Pasz-Walczak G, Sygut A, Dziki A, Kruk-Jeromin J (2011) Angiogenesis markers quantification in breast cancer and their correlation with clinicopathological prognostic variables. Pathol Oncol Res 17:809–817

    Article  PubMed  CAS  Google Scholar 

  48. Wiseman DA, Werner SR, Crowell PL (2007) Cell cycle arrest by the isoprenoids perilly alcohol, geraniol, and farnesol is mediated by p21(Cip1) and p27(Kip1) in human pancreatic adenocarcinoma cells. J Pharmacol Exp Ther 320:1163–1170

    Article  PubMed  CAS  Google Scholar 

  49. Vieira A, Heidor R, Cardozo MT, Scolastici C, Purgatto E, Shiga TM, Barbisan LF, Ong TP, Moreno FS (2011) Efficacy of geraniol but not of β-ionone or their combination for the chemoprevention of rat colon carcinogenesis. Braz J Med Biol Res 44:538–545

    PubMed  CAS  Google Scholar 

  50. Ahmad ST, Arjumand W, Seth A, Nafees S, Rashid S, Ali N, Sultana S (2011) Preclinical renal cancer chemopreventive efficacy of geraniol by modulation of multiple molecular pathways. Toxicology 290:69–81

    Article  PubMed  CAS  Google Scholar 

  51. Kim SH, Bae HC, Park EJ, Lee CR, Kim BJ, Lee S, Park HH, Kim SJ, So I, Kim TW, Jeon JH (2011) Geraniol inhibits prostate cancer growth by targeting cell cycle and apoptosis pathways. Biochem Biophys Res Commun 407:129–134

    Article  PubMed  CAS  Google Scholar 

  52. Burke YD, Stark MJ, Roach SL, Sen SE, Crowell PL (1997) Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol. Lipids 32:151–156

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors gratefully acknowledge Ms. C. D. Mohanapriya, Application Specialist, Central Research Facility, Sri Ramachandra Medical College and Research Institute, Chennai-600 116, Tamil Nadu, India for her valuable help in RT-PCR analysis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shanmugam Manoharan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vinothkumar, V., Manoharan, S., Sindhu, G. et al. Geraniol modulates cell proliferation, apoptosis, inflammation, and angiogenesis during 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis. Mol Cell Biochem 369, 17–25 (2012). https://doi.org/10.1007/s11010-012-1364-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-012-1364-1

Keywords

Navigation